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Sodium glomerulopathy: Tubuloglomerular feedback and renal
injury in African Americans. African Americans are prone to
develop not only essential hypertension but also progressive re-
nal injury. We present a simple model to explain salt-induced
renal injury (sodium glomerulopathy) in African Americans,
the central features of which are the tubuloglomerular feed-
back and the balance/imbalance between the vascular tones
of the afferent and efferent glomerular arterioles. We propose
that in African Americans, habitual consumption of high salt
causes chronic intermittent tubular hyperperfusion of the mac-
ula densa, resulting in a rightward and upward resetting of the
operating point for the tubuloglomerular feedback. The reset-
ting of the operating point causes an imbalance between the
vascular tones of the afferent/efferent arterioles, a rise in the
glomerular capillary hydraulic pressure, and consequent hyper-
filtration. Increased susceptibility to glomerular hyperfiltration
of African Americans on a high salt intake may explain their
proclivity to progressive renal injury associated with essential
hypertension.
In practically all epidemiologic studies examining
blood pressure profiles in African Americans, ethnicity
is based on self-report, which confounds the identifica-
tion of ethnic-specific factors (e.g., genes) in this admixed
population. This weakness notwithstanding, self-report
is of considerable value for epidemiologic surveys. Al-
though this paper treats African Americans as a group,
susceptibility to salt-induced physiologic responses, in-
cluding hypertension, shows wide interindividual vari-
ability among both African Americans and Caucasians.
In addition, African Americans differ from Caucasians
in a host of socioeconomic and other demographic fac-
tors that contribute to the phenotypic features of com-
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plex genetic traits, including essential hypertension and
“salt sensitivity,” and one may not be able to completely
disentangle a contribution of ethnicity from that of the
environment [1]. It is clear, nonetheless, that based on
reported ethnicity, the prevalence of essential hyperten-
sion and its renal complications, including end-stage renal
disease (ESRD), is considerably higher in African Amer-
icans than in Caucasians [2–5].
“Salt sensitivity,” usually taken to mean the rise in
blood pressure resulting from short-term manipulations
that increase sodium intake, is thought to predispose in-
dividuals habitually ingesting a high salt diet to hyperten-
sion. The higher prevalence of “salt sensitivity” in African
Americans parallels a higher incidence of hypertension
than in Caucasians throughout the first six decades of
life. The causes of these racial disparities remain as elu-
sive today as they were a generation ago. We contend
that abnormal regulation of renal sodium handling un-
derlies the predisposition of African Americans to hy-
pertension and further, that in itself a high salt intake in
African Americans may cause renal damage independent
of its effect on blood pressure, a phenomenon we term
“sodium glomerulopathy.” This idea is based on recent
insights into the operation of tubuloglomerular feedback
(TGF).
TGF
Mammalian kidneys have a remarkable capacity to
control the flow of urine in the renal tubules [6–13].
TGF regulates distal tubular sodium load by adjusting
glomerular filtration rate (GFR) in response to signals
received from the macula densa. When the macula densa
senses a decline in the delivery of NaCl to the distal
tubule, it signals the afferent arteriole to vasodilate, which
results in an increase in glomerular capillary hydraulic
pressure (GCHP) and a rise in GFR. This, in turn, in-
creases the renal tubular flow and sodium delivery to the
distal tubule. Increased distal NaCl delivery constricts
the afferent arteriole, lowers GCHP, slows GFR, and
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Fig. 1. The relation between the glomerular filtration rate (GFR) and
the distal NaCl delivery, as expressed in tubular glomerular feedback
(TGF). A resetting of the operating point downward and to the left
occurs in depletion of the extracellular fluid volume (ECFV) (i.e., de-
hydration). A resetting of the operating point upward and to the right
occurs in expansion of the ECFV or in a sustained increase in the de-
livery of NaCl to the distal tubules [i.e., tubular hyper-perfusion of the
macula densa (MD)] under euvolemic condition. The vascular tone
(vasodilation or vasoconstriction) of the afferent arterioles is the main
mechanism of the change in the GFR. Resetting of the TGF operating
point is largely dependent on the balance between the levels of an-
giotensin II, extracellular adenosine, and nitric oxide in the vicinity of
the glomerular arterioles. Figure is a modified version of Figure 2 in [6]
with permission to reproduce granted by Schnermann J and Briggs JP,
and J Clin Invest.
diminishes tubular flow. This relationship between GFR
and distal tubular NaCl delivery is nonlinear (Fig. 1). Un-
der normal conditions, the regulatory operating point is
at the steep part of the curve where gain is greatest. TGF
is responsive to the short-term (seconds) and, through ad-
justment of the TGF operating point, long-term changes
in distal tubular sodium load.
Under conditions of a reduction in the extracellular
fluid volume (ECFV), for instance, dehydration, there is
a decline in NaCl delivery to the distal tubules, a scenario
which would be expected to cause the macula densa to ef-
fect afferent arteriolar vasodilatation and increase GFR.
However, in the face of decreased ECFV, further sodium
loss would be maladaptive. Continued loss of sodium is
prevented by a shift of the operating point for activation
of the TGF to the left and downward (Fig. 1). The op-
posite occurs with kidney growth, pregnancy and under
conditions of ECFV expansion: the operating point for
TGF is reset to the right and upward, functioning at a
higher GFR (glomerular hyperfiltration) for any given
distal sodium delivery (Fig. 1). Resetting of the TGF
operating point appears to be mediated by a shifting
balance between factors such as angiotensin II, extracel-
lular adenosine, and nitric oxide in the proximity of the
glomerular arterioles [6–9].
DEFINITION OF GLOMERULAR
HYPERFILTRATION
Conventionally, glomerular hyperfiltration is defined
as an abnormal absolute elevation of GFR. Because
TGF regulation is operative over a wide range of tubu-
lar sodium concentrations and GFRs, we emphasize that
glomerular hyperfiltration in the context of our model
means that the afferent arterioles are relatively more va-
sodilated (or the efferent arterioles are relatively more
constricted) than they should be to maintain an appropri-
ate GFR for a given renal plasma flow (RPF), regardless
of whether absolute GFR is reduced, normal or increased.
Furthermore, such an imbalance between afferent and ef-
ferent arteriolar tones increases GCHP.
TGF AND GLOMERULAR HYPERFILTRATION
WITHOUT APPARENT EXPANSION
IN THE ECFV
Experiments in rats indicated that even without the
expansion of the ECFV, a sustained increase in NaCl
delivery to the distal tubule and hyperperfusion of the
macula densa, resulted in increased GFR and a right-
ward and upward resetting of the TGF operating point
[6, 7, 10]. Under euvolemic conditions sustained inhibi-
tion (for hours) of carbonic anhydrase in the proximal
tubules decreased proximal sodium reabsorption and in-
creased distal tubular sodium delivery. Upon cessation
of carbonic anhydrase inhibition, proximal sodium reab-
sorption reverted toward normal, and GFR became su-
pernormal [6, 7], meaning that sustained hyperperfusion
of the macula densa resetted the TGF operating point and
promoted, via temporal adaptation of TGF, glomerular
hyperfiltration.
Under physiologic conditions, daily fluctuations in
sodium delivery to the macula densa occur in shorter time
spans than experiments described above. Therefore, re-
setting of TGF upward and rightward may only result in
reversion of the GFR toward basal level without abso-
lute elevation in the GFR. In addition, the response of
the glomerulus to signals from the macula densa is so
rapid that the flow rate change in the proximal tubules
may be hardly noticed.
We note that the bulk of the daily sodium load is deliv-
ered episodically during and for variable time intervals
after meals. It is reasonable to assume, therefore, that
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mealtimes and the immediate postprandial period are
marked by sustained surges in the distal delivery of
sodium due to a decline in proximal tubular reabsorp-
tion of the ion (i.e., hyperperfusion of the macula densa).
If so, it is likely that in susceptible subjects, the rightward
and upward resetting of the TGF operating point dur-
ing a meal and the immediate postprandial period would
lead to a higher GFR for a given RPF (i.e., glomerular
hyperfiltration as proximal sodium reabsorption reverts
toward basal state prior to the subsequent meal). We
propose that this phenomenon occurs more commonly
in African Americans than in Caucasians and predis-
poses some African Americans to progressive renal in-
jury, which sometimes may occur without the presence of
hypertension.
GLOMERULAR HYPERFILTRATION AND ITS
POTENTIAL LINK WITH TUBULAR
HYPERPERFUSION OF THE MACULA DENSA
IN AFRICAN AMERICANS
The concept of a proclivity to glomerular hyperfiltra-
tion in African Americans due to the rightward and up-
ward resetting of the TGF operating point hinges on
the premise that, at least episodically, NaCl delivery to
the distal tubules is higher in African Americans than in
Caucasians. Support for this idea is derived from several
lines of evidence. PRA is lower in both normotensive
and hypertensive African Americans than in their Cau-
casian peers [14–17], a finding that has been interpreted
as indicating a relative expansion of the ECFV in African
Americans. Yet, there is no compelling evidence for in-
creased ECFV in normotensive or hypertensive African
Americans [17–19]. Whether or not the ECFV in African
Americans is expanded, low PRA points to an increase
in distal delivery of NaCl and tubular hyperperfusion
of the macula densa in this racial group [20–23]. It is
noteworthy, however, that factors other than reduction
in renin release by increased NaCl delivery to the macula
densa can cause low PRA, including reduced generation
of angiotensin I, low potassium intake, impaired renal
hemodynamics, and mineralocorticoid excess, but it is
doubtful that these mechanisms account for the low PRA
in African Americans [24, 25].
Increased NaCl delivery to the distal tubule could
also explain why thiazide diuretics exert a better anti-
hypertensive effect in African Americans compared to
beta-adrenergic receptor blockers [26–30], and why these
diuretics are more effective antihypertensives in African
Americans than in Caucasians [31, 32]. To maintain over-
all sodium balance in the face of increased distal sodium
delivery, African Americans would have to reabsorb
sodium in the distal tubules more avidly than Caucasians.
Increased distal reabsorption may be accomplished by
the thiazide-sensitive NaCl cotransport [33], and thus in-
hibition of this transport system by thiazides would result
in a greater antihypertensive response in African Amer-
icans than in Caucasians. We note, nonetheless, that a
study in a small cohort, comprising nine African Amer-
icans and nine Caucasians, showed a comparable natri-
uretic response in both groups in response to a single
dose of hyrochlorothiazide [34]. In and of itself, this ob-
servation does not weaken our model. But the question
of racial differences in natriuretic (and kaliuretic) re-
sponse to thiazide diuretics are worth pursuing in large
cohorts.
Given that clinical observations support the concept
of an increased sodium delivery to the distal tubules in
African Americans, the question that logically follows
is whether evidence exists for an imbalance of vascular
tone between the afferent and efferent arterioles caus-
ing glomerular hyperfiltration in African Americans on
a high salt intake. Parmer, Stone, and Cervenka [35] ob-
served that high salt intake caused an increase in the GFR
in African Americans but not in Caucasians for a given
RPF. More recently, Price et al [36] observed that during
a high salt intake there was no racial difference in GFR,
but RPF was lower in African Americans than in Cau-
casians. Therefore, GFR was relatively higher in relation
to the RPF in African Americans than in Caucasians.
In addition, during high salt intake, inhibition of the
intrarenal renin-angiotensin system by an angiotensin-
converting enzyme (ACE) inhibitor resulted in a consid-
erably greater increase in RPF in African Americans than
in Caucasians without any apparent change in GFR in ei-
ther racial group. Racial differences were not observed
when subjects were maintained on a low salt intake [37].
Such findings suggest that an imbalance between afferent
and efferent arteriolar tone accounts for the tendency
toward a higher GFR for a given RPF (i.e., glomeru-
lar hyperfiltration) in sodium-replete African Americans.
Low sodium intake or inhibition of the intrarenal renin-
angiotensin system abolishes this racial difference.
We note that once glomerular hyperfiltration occurs, it
is difficult to discern cause from effect in the tubular han-
dling of sodium. When this is the case, there must be an
increase of absolute sodium reabsorption not only by the
distal tubules but also by the proximal tubules to compen-
sate for the increased filtered sodium load and maintain
sodium balance [38, 39]. Under such circumstances, be-
cause of the increase in the filtered sodium load, the de-
livery of sodium to the macula densa would still be high,
sustaining the suppression of renin release from juxta-
glomerular cells. We also note that our model was crafted
with a view that glomerular hyperfiltration due to tubu-
lar hyperperfusion of the macula densa may occur with-
out the expansion of the ECFV. However, as shown in
Figure 1, the model would definitely fit the conventional,
albeit not fully substantiated, view that the ECFV is ex-
panded in African Americans on a high salt diet.
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RAMIFICATIONS WITH RESPECT TO RENAL
DAMAGE IN AFRICAN AMERICANS
Our model of TGF-mediated imbalance in the vas-
cular tone between the afferent and efferent arterioles
explains the predilection of a subset of African Amer-
icans to progressive renal damage that may complicate
essential hypertension. Such an imbalance results in a
greater transmission of high systemic pressure through
relatively vasodilated afferent arterioles to the glomeru-
lar capillaries, increasing GCHP. We note that an increase
in the GCHP, as an outcome of “salt sensitivity,” may
apply not only for African Americans but also other in-
dividuals [40]. It appears, however, that the sequela of
this phenomenon are more widespread among African
Americans. It is also plausible that a “sodium glomeru-
lopathy” accounts for renal injury in a subset of African
Americans, regardless of the presence of hypertension.
In such patients, an increased distal sodium load aris-
ing from a high salt diet could result in TGF-mediated
glomerular hyperfiltration. Thus, in some African Amer-
icans, tubular hyperperfusion of the macula densa could
be the primary mechanism promoting renal damage.
Regardless of the primary cause of essential hyperten-
sion, tubular hyperperfusion of the macula densa with
or without hypertension would lead to a self-destructive
loop of progressive renal damage, provocation or ex-
acerbation of hypertension, and progressive glomeru-
lar damage (Fig. 2). We also suspect that the increased
predilection of African Americans to progressive renal
injury associated with diabetes mellitus, a disorder com-
plicated by glomerular hyper-filtration, may arise from
an exacerbation of their innate tendency to glomerular
hyperfiltration.
The matter of causality, that is, whether renal damage
begets hypertension or vice versa is of great interest, par-
ticularly in light of the familial clustering of ESRD [41,
42] and the demonstration of genetic linkage of creati-
nine clearance and renal failure phenotypes to a locus
on human chromosome 10 [43, 44]. A recent communi-
cation extensively reviewed experimental and some clin-
ical findings supporting the concept that essential hyper-
tension, and particularly the “salt sensitive” type hyper-
tension, may arise from an intrinsic renal disease [45].
The authors proposed that the “salt sensitive” type of
essential hypertension might result from a hyperactive
sympathetic nervous system that causes renal vasocon-
striction (primarily involving the afferent arterioles) and
leads to renal ischemia. Renal ischemia is postulated to
evoke a chain of events culminating in the development
of hypertension. The evidence provided in support of this
model is largely from experimental studies in laboratory
animals and from observations of renal injury resulting
from agents toxic to the kidney. Thus, the model’s appli-
cability to renal disease encountered clinically in African
Americans might be questioned. Nonetheless, it suggests,
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Fig. 2. Schematic description of sodium glomerulopathy in African
Americans. The model centers on hyperperfusion of the macula densa
(MD) with or without the expansion of the extracellular fluid volume
(ECFV) as the cause, through tubular glomerular feedback (TGF), of
an imbalance between the afferent and the efferent arterioles. Such an
imbalance is expressed in a state in which the afferent arterioles are
relatively more vasodilated, or the efferent arterioles are more vaso-
constricted than they should be. This would lead to an increase in the
glomerular capillary hydraulic pressure (GCHP) and sodium glomeru-
lopathy, which may lead to hypertension. The model also suggests a
positive feedback loop through which hypertension caused by either
sodium glomerulopathy (secondary hypertension) or hypertension due
to other causes (primary hypertension) exacerbates the renal damage
caused by an imbalance between the afferent and efferent arterioles. +
sign denotes an amplifying effect.
as does our model, that intrinsic renal damage may be a
primary determinant in the development of essential hy-
pertension. Regardless of the etiology of renal damage,
if intrinsic renal disease causes the “salt sensitive” type
of essential hypertension, an effective treatment of the
underlying causes of essential hypertension must be ini-
tiated before the onset of hypertension. In other words,
early intervention is paramount; once hypertension is
present, renal damage has already occurred.
THE POSSIBLE BIOLOGIC MEANING OF “SALT
SENSITIVITY” IN AFRICAN AMERICANS
What then is “salt sensitivity,” particularly as it per-
tains to the pathophysiology of essential hypertension
in African Americans? What “salt sensitivity” tradition-
ally entails with regard to blood pressure is a shift in the
pressure-natriuresis curve, so that “salt sensitive” sub-
jects excrete the same amount of sodium as “nonsalt-
sensitive” subjects, but at a higher blood pressure [46]. It
is evident from our model that another mechanism medi-
ated by a primary increase in GCHP may facilitate natri-
uresis without a salt-mediated rise in blood pressure, This
suggests the intriguing possibility that glomerular hyper-
filtration in African Americans on a high salt intake is
a renal maladaptation, serving to meet the daily excre-
tion of sodium load to overcome an inadequate tubular
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excretory capacity of sodium that is probably due to avid
sodium reabsorption distal to the proximal tubules. This
task can then be achieved with small or no rise in blood
pressure, but at the expense of an increase in GCHP. It is
the chronic increase in GCHP that ultimately causes renal
damage and perhaps hypertension in susceptible African
Americans who habitually consume a high salt diet. This
concept of renal maladaptation in African Americans
must be considered from the standpoint that it predis-
poses to renal disease under present living circumstances,
reflecting dietary and environmental settings that exist in
industrialized nations.
RAMIFICATIONS WITH RESPECT TO THERAPY
With or without association with essential hyperten-
sion or diabetes mellitus, if glomerular hyperfiltration
is deleterious [47], preventing or ameliorating its effects
may be beneficial. ACE inhibitors and angiotensin II an-
tagonists attenuate the progression of renal damage in
African Americans and Caucasians with essential hyper-
tension and diabetes mellitus, presumably through sup-
pression of the intrarenal renin-angiotensin system [48–
54]. We note, however, that this favorable effect does not
necessarily imply that the intrarenal renin-angiotensin
system is hyperactive in individuals suffering progres-
sive renal damage associated with essential hypertension
or diabetes mellitus. In the context of our model, ACE
inhibitors and angiotensin II antagonists would be ex-
pected to slow the progression of renal injury by vasodi-
lating efferent arterioles more than afferent arterioles.
In other words, since an imbalance between the vascular
tone of afferent and efferent arterioles is a major cause of
progressive renal derangement in hypertensive African
Americans, blockade of the intrarenal renin-angiotensin
system restores the balance and lowers GCHP. The find-
ings of the recently completed African American Study of
Kidney Disease (AASK) Trial further support our model,
particularly with regard to African Americans [55]. In this
study the ACE inhibitor ramipril was superior to meto-
protol and amlodipine in slowing progressive renal dam-
age, despite equivalent antihypertensive effects of the
three agents.
The intrarenal renin-angiotensin is an important mod-
ulator of TGF regulation. Whether angiotensin II acts as
a primary agent or a modulator for the effects of other
factors in TGF is not entirely clear, but there is evidence
that an interplay among angiotensin II, nitric oxide, and
extracellular adenosine adjacent to the macula densa is
central to TGF [8, 9, 56]. If only the afferent arterioles
were the target of the intrarenal angiotensin II, inhibition
of the intrarenal renin-angiotensin system might actually
increased GCHP and exacerbated glomerular hyper-
filtration. This would have occurred by removing the
vasoconstrictor effect of angiotensin II and leaving unop-
posed the vasodiliatory effect of nitric oxide on afferent
arterioles. However, the observation that ACE inhibition
increases RPF without raising GFR in sodium-replete
subjects [35, 57, 58] suggests that the intrarenal renin-
angiotensin system exerts effects on both afferent and
efferent arterioles. Similarly, evidence points to both af-
ferent and efferent arteriolar resistance regulation by
nitric oxide [59]. Collectively, these observations demon-
strate that the benefit of antagonism of the intrarenal
renin-angiotensin system in patients with glomerular hy-
perfiltration is largely due to its greater vasorelaxing
influence on the efferent than afferent arterioles. By
decreasing efferent arteriolar resistance, ACE inhibitors
and angiotensin II antagonists would reduce GCHP in
hypertensive African Americans.
MODEL LIMITATIONS AND RAMIFICATIONS
WITH RESPECT TO ADDITIONAL RESEARCH
Some readers may justifiably consider our model to be
not only too simplistic but also incomplete. The model
does not include, for instance, the ultrafiltration coeffi-
cient of the glomerular capillaries, a variable that may be
modified in some of the experimental and clinical circum-
stances described above. In addition, it does not include
the myogenic reflex in the afferent arterioles, which is an
important factor in the autoregulation of renal blood flow
and GFR [60]. However, we believe the simplicity of the
model captures the key pathophysiologic processes medi-
ating renal injury in African Americans and offers a clear
framework for testing its implications in humans. The ul-
trafiltration coefficient of the glomerular capillaries, the
afferent arteriolar resistance and for that matter GCHP
cannot be measured in humans. But one can estimate (and
manipulate) sodium delivery to the distal tubule and as-
sess the relationship between sodium reabsorption by the
proximal tubules and the GFR/RPF ratio.
In free-living subjects, under steady-state conditions,
urinary sodium excretion simply reflects the amount of
consumed sodium. There is no merit to claims that “salt-
sensitive” subjects excrete less sodium in the urine. If this
occurred, “salt-sensitive” subjects would have exhibited
a progressive increase in the ECFV, which is a physiologic
impossibility. “Salt-sensitive” African Americans excrete
the same daily sodium load as non-“salt sensitive” sub-
jects, but at a higher blood pressure, at a higher GCHP (as
we propose), or both. And herein rests the fundamental
issue pertaining to our model and the general question
of “salt sensitivity” in African Americans. Findings that
African Americans have an increased proximal sodium
reabsorption would support the conventional view that
“salt sensitivity” in African Americans is expressed by
ECFV expansion. Elevated blood pressure in African
Americans on a high salt diet would therefore serve to
keep them in salt balance. Such a scenario may explain
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the predilection of African Americans to essential hy-
pertension but not to renal injury. In contrast, findings
of an increased distal sodium delivery in African Amer-
icans would explain this predilection without the neces-
sity of invoking an expansion of the ECFV in this ethnic
group. Most important, these findings would provide a
reasonable explanation for the susceptibility of African
Americans not only to essential hypertension, but also
to the renal injury resulting from or associated with this
disorder. Thus, presently, the most important test of our
model is whether distal delivery of sodium is higher in
healthy, normotensive African Americans on a high salt
intake than in their Caucasian peers. Studies in hyperten-
sive African Americans would not be as insightful in this
regard, as subjects may already suffer from subclinical re-
nal damage. Moreover, some may also express glomeru-
lar hyperfiltration, which, as indicated earlier, would dis-
tort the relationship between proximal vs. distal sodium
reabsorption.
Other promising lines of inquiry for future research
concern the role of nitric oxide and the renin-angiotensin
system in glomerular hyperfiltration in African Amer-
icans. Three nitric oxide synthase isoforms, including
neuronal, inducible, and endothelial isoforms, are ex-
pressed in the kidney, and the neuronal isoform is highly
expressed in macula densa cells [61, 62]. This distri-
bution suggests a potential role of nitric oxide in sus-
taining glomerular hyperfiltration in African Americans
on a high salt intake, since the rightward and upward
resetting of the TGF set point with or without ECFV ex-
pansion may be mediated by nitric oxide [6, 7]. More-
over, the neuronal isoform of nitric oxide synthase is
calcium dependent [63] and it regulates the signal trans-
mitted from the macula densa to afferent arterioles. Such
features link cytosolic calcium regulation in the macula
densa with TGF. The neuronal isoform of nitric oxide
synthase has recently been reported to be significantly
associated with ESRD in African Americans [64]. Ge-
netic variants with differing allelic frequencies of genes
in control of the renin-angiotensin system [65–69] in
African Americans and Caucasians may also be poten-
tial candidates for a genetic predisposition of African
Americans to ”salt-sensitivity,” hypertension or renal
damage.
ALTERNATIVE CONSIDERATIONS
A key feature of our pathophysiologic model is the
upward and rightward resetting of the TGF operating
point, a process that sustains glomerular hyperfiltration
chronically. While we propose that this resetting results
from intermittent but chronic hyperperfusion of macula
densa, alternative explanations may be entertained. For
instance, alterations in the regulation of cytosolic calcium
in the macula densa, sensitivity of the macula densa to
tubular sodium, the transduction of signals arising in the
macula densa to the afferent arterioles or the vasodila-
tory response of the afferent arterioles to those signals
may result in an inappropriately high GCHP for a given
RPF. Perhaps the most interesting alternative hypothesis
is that an increase in Na-K-2Cl cotransport in the ascend-
ing limb of Henle’s loop and in the macula dense may
result in low PRA and the resetting of the TGF upward
and rightward. In principle, this and other hypothese can
be considered for a TGF-mediated renal injury associ-
ated with glomerular hyperfiltration, even when there is
no evidence for an increased sodium delivery to the distal
tubules.
CONCLUSION
The renal complications of essential hypertension and
diabetes mellitus are, of course, not limited to African
Americans, but national surveys and epidemiologic stud-
ies have underscored the magnitude of the problem in
this racial group and project an increased incidence of
ESRD for the next few decades. The human toll, in terms
of morbidity and mortality resulting from ESRD, is stag-
gering. Additionally, the economic burden of dialysis and
renal transplantation, even assuming that donor kidneys
are available, is enormous and will continue to increase.
Reversing these trends will require an understanding of
the pathophysiologic mechanisms promoting renal injury
in humans; such mechanisms should permit targeting of
therapies likely to be most effective for the treatment, and
perhaps the prevention, of renal disease. This is particu-
larly important as recent findings suggest that elevated
blood pressure in childhood is associated with microal-
buminuria (i.e., renal damage) in adulthood in African
Americans but not in Caucasians [70].
Unfortunately, there is distressingly little research re-
lated to the study of these mechanisms in humans. The
findings that have emerged from studying laboratory ani-
mals with genetic hypertension, particularly with regards
to how genes relate to physiologic and biochemical phe-
notypes and how genes and environment interact, have
been highly relevant. For example, the functions of renin-
angiotensin aldosterone system are common to all mam-
mals, and it is perhaps only through animal models that
the vast and diverse scope of biologic activities of this
system in relation to salt intake has been fully appreci-
ated. Understanding the extensive involvement of this
system in mammalian biology was critical for the de-
velopment of ACE inhibitors and angiotensin receptor
blockers not only in essential hypertension but also for
congestive heart failure and diabetic nephropathy. More-
over, the recent observation that ACE 2 messenger RNA
and protein expressions are down-regulated in kidneys of
hypertensive rat strains [71] points to a heretofore unex-
plored role of the renin-angiotensin aldosterone system
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in the pathophysiology of hypertension and cardiovascu-
lar disease.
It is noteworthy, however, that the enormous corpus of
experimental data on genetic animal models of hyperten-
sion has been taken on faith to relate to human essential
hypertension and its complications with only pro forma
acknowledgment of the peril of extrapolating from find-
ings in inbred laboratory animals with hypertension to
human hypertension. We must recognize, hence, as we
grapple with the enigma of “salt sensitivity” and renal
disease in African Americans, that the solution to ques-
tions regarding these human traits must be approached
primarily through clinical research. Such research should
focus not only on patients with essential hypertension,
but also on healthy African Americans and Caucasians.
In this way, we may be able to untangle causality from
consequence in the search for explanations of the racial
disparity in ESRD.
Finally, evolutionary trajectories are largely defined by
shifts in frequencies of variant genes within populations,
and such shifts may well have differed in African Amer-
icans and Caucasians. The racial differences in allelic ex-
pressions of genes engaged in the control of the renin-
angiotensin system, coupled with the racial disparity in
“salt sensitivity,” demand an evolutionary explanation if
we are to fully address issues of why physiologically adap-
tive systems become maladaptive in the contemporary
environment.
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